Slater, Holli
AlZubi, Yasmin
Rezaeizadeh, Afsaneh
Hughes, Jennifer L.
Gorman, April
Mayes, Taryn L.
Elmore, Joshua S.
Storch, Eric A.
Wakefield, Sarah M.
Trivedi, Madhukar H.
Funding for this research was provided by:
National Center for Advancing Translational Sciences of the National Institutes of Health (UL1 TR003163)
Texas Child Mental Health Care Consortium
Article History
Accepted: 7 December 2023
First Online: 10 February 2024
Declarations
:
: Dr. Hughes reports receiving research funding to her institution from NIH. She reports receiving support from the Society of Clinical Child and Adolescent Psychology, the Jed Foundation, and Mental Health in Mind, International AB, and consulting on quality improvement interventions for depression and suicidal/self-harm behavior. She receives book royalties from Guilford Press. Dr. Storch reports receiving research funding to his institution from the Ream Foundation, International OCD Foundation, and NIH. He is a consultant for Brainsway and Biohaven Pharmaceuticals. He owns stock less than $5000 in NView. He receives book royalties from Elsevier, Wiley, Oxford, American Psychological Association, Guildford, Springer, Routledge, and Jessica Kingsley. Dr. Trivedi has provided consulting services to Alkermes Inc, Axsome Therapeutics, Biogen MA Inc., Cerebral Inc., Circular Genomics Inc, Compass Pathfinder Limited, GH Research Limited, Heading Health Inc, Janssen, Legion Health Inc, Merck Sharp & Dohme Corp., Mind Medicine (MindMed) Inc, Merck Sharp & Dhome LLC, Naki Health, Ltd., Neurocrine Biosciences Inc, Noema Pharma AG, Orexo US Inc, Otsuka American Pharmaceutical Inc, Otsuka Canada Pharmaceutical Inc, Otsuka Pharmaceutical Development & Commercialization Inc, Praxis Precision Medicines Inc, SAGE Therapeutics, Sparian Biosciences Inc, Takeda Pharmaceutical Company Ltd, WebMD. He sits on the Scientific Advisory Board of Alto Neuroscience Inc, Cerebral Inc., Compass Pathfinder Limited, Heading Health, GreenLight VitalSign6 Inc, Legion Health Inc, Merck Sharp & Dohme Corp, Orexo US Inc, Signant Health. He holds stock in Alto Neuroscience Inc, Cerebral Inc, Circular Genomics Inc, GreenLight VitalSign6 Inc, Legion Health Inc. Additionally, he has received editorial compensation from American Psychiatric Association, and Oxford University Press. Dr. Slater, Ms. AlZubi, Ms. Rezaeizadeh, Ms. Gorman, Ms. Mayes, Mr. Elmore, and Dr. Wakefield have no declarations to report.
: The UT Southwestern IRB served as a single IRB of record for all Nodes; Node IRBs also reviewed the study. For participants under 18 years of age, a parent or guardian provides written informed consent, and the adolescent provides written informed assent. For participants ages 18 years and older, the participant provides written informed consent. Data presented within this manuscript are related to node-subsites; participant level data is not presented.